1. Attal N, Cruccu G, Baron R, Haanpää M, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain. 2010 revision. Eur J Neurol 2010,17:1113–23.
2. Babbar S. Pharmacokinetic analysis of capsaicin after topical administration of a high concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit 2009;31:502–10.
3. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults (review). Cochrane Database Sys Rev 2009;4:CD007393.
4. Jensen Troels S, Madsen Caspar S, et al. Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 2009;22:467–74.
5. Kennedy WR, Vanhove GF, Lu S, Tobias J, et al. A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 2010,11: 579–87.
6. Manchikanti L, Fellows B, Singh V. Understanding psychological aspects of chronic pain in interventional pain management. Pain Physician 2002;5:57–82.
7. Miller MS, Buck SH, Sipes GI, Yamamura HI, et al. Regulation of substance P by nerve growth factor: Disruption by capsaicin. Brain Res 1982;250:193–6.
8. Neuropathic Pain Network. www.neuropathicpainnetwork.org/emglish/index. asp, Stand 23.10.2009.
9. Palazzzo E, Rossi F, Maione S. Role of TRPV1 receptors in descending modulation of pain. Mol Cell Endocrinol 2008;286S:S79–83.
10. Treede RD, Jensen TS, Campbell JN, Cruccu G, et al. Neuropathic pain – Redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5.
Dr. med. Uwe Kern, Schmerzzentrum Wiesbaden, Langenbeckplatz 2, 65189 Wiesbaden, E-Mail: firstname.lastname@example.org